Ortizo, Rubie .
HRN: 10-43-62 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/30/2023
AMPICILLIN 1GM (VIAL)
10/30/2023
11/06/2023
IV
2gm
Q6
Prom X 14 Hrs
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes